Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Drug

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   


ftld4 - morphometry1 - tasigna1 - behavioral problems1 - ziveri1 - mental decline2 - memory impairment2 - treatment for huntington disease1 - brain damage2 - fischer1 - cerebrovascular disease1 - early-onset alzheimer's1 - blood pressure6 - healthy diet1 - dementia cases2 - amyloid plaque4 - islet amyloid polypeptide1 - abeta plaque1 - bucknill1 - mayo clinic1 - involuntary movements2 - antiviral drugs1 - brain cell damage2 - pick’s disease1 - brain plaques1 - autism spectrum1 - developing dementia2 - sunflower oil1 - kraepelin3 - amyloid-β421 -